Change in serum uric acid between baseline and 1-year follow-up and its associated factors in male subjects

Clinical Rheumatology

Volumn 27, Issue 4, 2008, Pages 483-489

  Choe, Jung Yoon ^a   Park, Sung Hoon ^a   Kim, Ji Young ^a   Shin, Im Hee ^a   Kim, Seong Kyu ^a  

^a Catholic University of Daegu   (South Korea)

Author keywords

Creatinine; Uric acid

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; ELECTROLYTE; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LACTATE DEHYDROGENASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITROGEN; PHOSPHORUS; TRIACYLGLYCEROL; UREA; URIC ACID;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD PRESSURE; BODY HEIGHT; CARDIOVASCULAR DISEASE; CONFIDENCE INTERVAL; CREATININE BLOOD LEVEL; DIABETES MELLITUS; ERYTHROCYTE SEDIMENTATION RATE; FOLLOW UP; HEALTH CENTER; HEART FAILURE; HUMAN; HYPERTENSION; HYPERURICEMIA; KIDNEY FUNCTION TEST; LIPID ANALYSIS; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; METABOLIC SYNDROME X; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SELF REPORT; UREA NITROGEN BLOOD LEVEL; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; BILIRUBIN; BLOOD UREA NITROGEN; CHOLESTEROL; CHRONIC DISEASE; COHORT STUDIES; CREATININE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PHOSPHORUS; REGRESSION ANALYSIS; TRIGLYCERIDES; URIC ACID;

EID: 41049101001     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-007-0732-9     Document Type: Article

References (30)

1. Ghei M, Mihailescu M, Levinson D (2002) Pathogenesis of hyperuricemia: recent advances. Curr Rheumatol Rep 4:270-274
2. Sica DA, Schoolwerth AC (2002) Part 1. Uric acid and losartan. Curr Opin Nephrol Hypertens 11:475-482
3. Enomoto A, Kimura H, Chairoungdua A et al (2002) Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 417:447-452
4. Shima Y, Teruya K, Ohta H (2006) Association between intronic SNP in urate-anion exchanger gene, SLC22A12, and serum uric acid levels in Japanese. Life Sci 79:2234-2237
5. Nan H, Qiao Q, Dong Y et al (2006) The prevalence of hyperuricemia in a population of the coastal city of Qingdao, China. J Rheumatol 33:1346-1350
6. Lohsoonthorn V, Dhanamun B, Williams MA (2006) Prevalence of hyperuricemia and its relationship with metabolic syndrome in Thai adults receiving annual health exams. Arch Med Res 37:883-889
7. Kim EH, Jeon K, Park KW et al (2004) The prevalence of gout among hyperuricemic population. J Korean Rheum Assoc 11:7-13
8. Rott KT, Agudelo CA (2003) Gout. JAMA 289:2857-2860
9. Rho YH, Choi SJ, Lee YH et al (2005) The prevalence of metabolic syndrome in patients with gout: A multicenter study. J Korean Med Sci 20:1029-1033
10. Mellen PB, Bleyer AJ, Erlinger TP et al (2006) Serum uric acid predicts incident hypertension in a biethnic cohort: The atherosclerosis risk in communities study. Hypertension 48:1037-1042
11. Conen D, Wietlisbach V, Bovet P et al (2004) Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health 4:9
12. Lin KC, Tsao HM, Chen CH et al (2004) Hypertension was the major risk factor leading to development of cardiovascular diseases among men with hyperuricemia. J Rheumatol 31:1152-1158
13. Culleton BF, Larson MG, Kannel WB et al (1999) Serum uric acid and risk for cardiovascular disease and death: The Framingham Heart Study. Ann Intern Med 131:7-13
14. Nakanishi N, Suzuki K, Kawashimo H et al (1999) Serum uric acid: correlation with biological, clinical and behavioral factors in Japanese men. J Epidemiol 9:99-106
15. Munan L, Kelly A, Petitclerc C (1976) Population serum urate levels and their correlates. The Sherbrooke regional study. Am J Epidemiol 103:369-382
16. Fang J, Alderman MH (2000) Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 283:2404-2410
17. Anonymous (1999) 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens 17:151-183
18. Anonymous (1997) Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20:1183-1197
19. Eckel RH, Grundy SM, Zimmet PZ (2005) The metabolic syndrome. Lancet 365:1415-1428
20. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486-2497
21. World Health Organisation Western Pacific Region (2000) The Asia-Pacific perspective: Redefining obesity and its treatment. Co-sponsored by the Regional Office for the Western Pacific, World Health Organization, International Association for the Study of Obesity and the International Obesity Task Force
22. Baillie JK, Bates MG, Thompson AA et al (2007) Endogenous urate production augments plasma antioxidant capacity in healthy lowland subjects exposed to high altitude. Chest 131:1473-1478
23. Lin JD, Chiou WK, Chang HY et al (2007) Serum uric acid and leptin levels in metabolic syndrome: A quandary over the role of uric acid. Metabolism 56:751-756
24. Rathmann W, Haastert B, Icks A et al (2007) Ten-year change in serum uric acid and its relation to changes in other metabolic risk factors in young black and white adults: The CARDIA study. Eur J Epidemiol 22(7):439-445. DOI 10.1007/s10654-007-9132-3
25. Perez-Ruiz F, Calabozo M, Herrero-Beites AM et al (2000) Improvement of renal function in patients with chronic gout after proper control of hyperuricemia and gouty bouts. Nephron 86:287-291
26. Darmawan J, Rasker JJ, Nuralim H (2003) The effect of control and self-medication of chronic gout in a developing country. Outcome after 10 years. J Rheumatol 30:2437-2443
27. Bairaktari E, Liamis G, Tsolas O et al (2001) Partially reversible renal tubular damage in patients with obstructive jaundice. Hepatology 33:1365-1369
28. Mielants H, Veys EM, de Weerdt A (1973) Gout and its relation to lipid metabolism. II. Correlations between uric acid, lipid, and lipoprotein levels in gout. Ann Rheum Dis 32:506-509
29. Shankar A, Klein R, Klein BE et al (2006) The association between serum uric acid level and long-term incidence of hypertension: population-based cohort study. J Hum Hypertens 20:937-945
30. Perlstein TS, Gumieniak O, Williams GH et al (2006) Uric acid and the development of hypertension: The normative aging study. Hypertension 48:1031-1036